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Polythiophene derivative on quartz resonators
for miRNA capture and assay†
Al. Palaniappan,*a,b Jamal Ahmed Cheema,a,b Deepa Rajwar,a,b
Gopal Ammanath,a,b,c Liu Xiaohu,a,b Lim Seng Koon,a,b Wang Yi,a,b
Umit Hakan Yildizd,e and Bo Liedberg*a,b
A novel approach for miRNA assay using a cationic polythiophene derivative, poly[3-(3’-N,N,N-triethyl-
amino-1’-propyloxy)-4-methyl-2,5-thiophene hydrobromide] (PT), immobilized on a quartz resonator is
proposed. The cationic PT enables capturing of all RNA sequences in the sample matrix via electrostatic
interactions, resulting in the formation of PT–RNA duplex structures on quartz resonators. Biotinylated
peptide nucleic acid (b-PNA) sequences are subsequently utilized for the RNA assay, upon monitoring the
PT–RNA–b-PNA triplex formation. Signal amplification is achieved by anchoring avidin coated nano-
particles to b-PNA in order to yield responses at clinically relevant concentration regimes. Unlike conven-
tional nucleic acid assay methodologies that usually quantify a specific sequence of RNA, the proposed
approach enables the assay of any RNA sequence in the sample matrix upon hybridization with a
PNA sequence complementary to the RNA of interest. As an illustration, successful detection of mir21,
(a miRNA sequence associated with lung cancer) is demonstrated with a limit of detection of 400 pM.
Furthermore, precise quantification of mir21 in plasma samples is demonstrated without requiring PCR
and sophisticated instrumentation.
Introduction
Over the past few years, optical properties of conjugated poly-
electrolytes (CPEs) have been exploited for applications in
nucleic acid assays.1–9 The assays are based on changes in the
optical properties of CPEs that are attributed to the polymer
backbone conformation. Upon interaction with nucleic acids,
positively charged CPEs form a complex and exhibit changes
in colorimetric and fluorometric signals that are enhanced by
a collective response. Recent studies have revealed that optical
property changes could even facilitate the naked eye detection
of nucleic acids.7–12 However, solution based methodologies
often encounter difficulties due to uncontrolled complexation,
therefore limiting the selectivity of the nucleic acid assay.13
Moreover, most of the approaches do not yield quantitative
analysis without inclusion of sophisticated optical characteri-
zation techniques. Optical methods further have limitations to
perform a quantitative nucleic acid assay in complex samples,
for instance serum. Furthermore, there is a need for a “mix-
and-measure” type assay to detect fragile gene fragments as
well as microRNA (miRNA) sequences. Therefore, spirited by
the recent advances in programmable complex formation
upon impregnation of CPEs on paper based solid substrates,14
we have attempted to utilize a polythiophene derivative which
is a cationic CPE, for the first time, as a responsive layer on a
resonator platform such as a quartz crystal microbalance
(QCM) for specific and quantitative analysis of miRNA. In this
report, the cationic polythiophene derivative, poly[3-(3′-N,N,N-
triethylamino-1′-propyloxy)-4-methyl-2,5-thiophene hydro-
bromide] (PT), is immobilized on the QCM surface for capturing
miRNA via electrostatic interactions.
Cationic PTs are utilized for maximizing the interaction
with negatively charged nucleic acids.8,9 They freely form
hydrogels with significant swelling at physiological pH facili-
tating complete capture of miRNA.15 As reported previously,
PT complexes with miRNA via electrostatic interactions yield-
ing a duplex structure.14,16 PT therefore captures the target
miRNA and other interfering miRNAs in complex samples.
Triplex formation or specific detection is achieved upon injec-
tion of a PNA sequence complementary to the target miRNA.
mir21, a miRNA sequence associated with lung cancer, is uti-
lized in the study for validation of the proposed approach.
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Several assay formats based on QCM have been reported,
usually involving a recognition molecule immobilized on the
QCM crystal surface that can specifically bind a target
analyte.17–19 As for the nucleic acid assay, PNA/DNA probes are
usually immobilized on the QCM surface for detection of a
particular DNA/RNA sequence of interest. Though sub-pM
detection sensitivities have been reported based on QCM,18,19
most of the reports possess the limitation of quantifying a
specific sequence of RNA in the sample matrix. Unlike conven-
tional nucleic acid probes that are immobilized on the QCM
surface, PT, proposed in this study, enables capturing all
miRNAs in a sample matrix, providing a unique possibility of
detecting any miRNA sequence upon injection of a peptide
nucleic acid (PNA) sequence complementary to the miRNA of
interest. Avidin coated nanoparticles (ANPs) are subsequently
utilized for signal amplification and to yield responses in clini-
cally relevant concentration regimes. Avidin functionalized
nanoparticles selectively bind to the biotin anchored to PNA.
ANPs serve as mass enhancers amplifying the PNA hybridi-
zation signal. QCM frequency shift responses are then directly
correlated with the miRNA concentration, thereby eliminating
the need for PCR upon miRNA isolation.
Experimental
All the chemicals for PT synthesis were purchased from
Sigma–Aldrich and used without further purification. De-
ionized (DI) MilliQ water (resistivity of 18 MΩ cm) was used for
buffer preparation and PT synthesis. Precursors 1 and 2 were
synthesized according to previous reports.20 Quaternization of
precursor 2 with triethylamine yielded monomer 1. PT was
subsequently synthesized by oxidative polymerization of
monomer 1 (Scheme 1). The structures of the precursors and
monomers were confirmed by NMR spectroscopy. The number
averaged molecular weight of the synthesized PT is estimated
to be between 6 and 10 kDa.21 Similarly, PT with a varying
pendant group was synthesized in order to investigate/opti-
mize its interaction with miRNA (Fig. S1†). A Perkin Elmer
Lambda 35 UV-vis spectrometer, Infinite M200Pro Tecan
plate reader and Thermo Scientific Nanodrop 2000c Spectro-
photometer were used for optical characterization of the
synthesized PT, prior to applying the polymer in the QCM
based assay.
5 MHz AT-cut piezoelectric quartz crystals coated with gold
were obtained from Q-Sense, Sweden. QCM crystals were
cleaned before use by first treating them with ozone for
10 min followed by sonication in 99% ethanol for 5 min. The
crystals were then rinsed with ethanol followed by DI water
and blown dry with N2. The cleaned crystals were mounted in
the microfluidic chamber of the Q-Sense instrument. Real
time QCM measurements were carried out using Q-Sense E4.
Upon attaining a stable resonant frequency, 250 µL of varying
concentrations of PT was injected (at a flow rate of 50 µL
min−1) into the QCM chamber. An optimized concentration of
0.1 mg ml−1 based on polymer loading was chosen for the
assay (Fig. S2†) to form a layer of ∼2.8 nm thickness (Fig. S3†).
PBS with 0.002% Tween (PBST) was used as a running buffer
solution and for PNA/miRNA dilutions.
The following miRNA and PNA sequences were purchased
from IDT and Panagene, respectively.
mir21: 5′-UAG CUU AUC AGA CUG AUG UUG A-3′
Non-complementary sequence (Nc): 5′-AUG CAU GCA UGC
AUG CAU GCA A-3′
Biotinylated PNA sequence (b-PNA): biotin – OO – 5′ TCA
ACA TCA GTC TGA TAA GCT A 3′, where O represents a glycol
spacer.
miRNA stock solutions of 100 µM were prepared with
RNase free DI water and stored at −20 °C. For miRNA assay, PT
addition was followed by injections of 250 µL of bovine serum
albumin (BSA, 5 mg ml−1), 250 µL of miRNA (at a varying con-
centration), 250 µL of b-PNA and 0.1 mg ml−1 ANP. ANP, pur-
chased from Chemicell GmbH, Germany, comprises of a
magnetite core covered in a starch matrix and functionalized
with avidin. The particles are of ∼100 nm in size and sus-
pended in PBS with 0.05% sodium azide buffer. Human
plasma was purchased from GeneTex, Taiwan for spiking
experiments, upon isolation of mir21 using Macherey-Nagel’s
Nucleospin miRNA extraction kit.
Results and discussion
Optical characterization of PT
In order to understand and validate PT as a responsive layer
upon interaction with mir21, absorption and fluorescence
spectra of 150 μM of PT in the presence and absence of 10 µM
miRNA were recorded at room temperature. The UV–Vis
absorption and emission maxima in DI water solution of PT
have been observed at 403 nm and 537 nm, respectively. These
peaks are due to the random coil morphology of the PT back-
bone and are in agreement with previous reports.14,22–24 Fig. 1a
Scheme 1 Synthesis of PT.
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and c show red shifts from the main absorption peak (403 nm)
upon addition of 30 µL of 10 µM mir21 and the Nc sequence
(red curves), respectively. For the mir21, redistribution of the
absorption spectrum with the main absorption peak at
442 nm, and two vibronic peaks at 541 nm and 589 nm was
observed, whereas a single broad absorption curve with
maxima at 439 nm was observed for Nc. This difference in the
absorption peak is possibly because of the difference in the
interaction mode of PT with mir21 and Nc, due to the very sen-
sitive nature of the PT backbone (changing conformation from
nonplanar to planar) towards different nucleotides. As
reported previously, the red shift is attributed to PT–miRNA
duplex formation governed by the electrostatic interactions
between PT and miRNA sequences.14 Fig. 1a shows that a pro-
minent blue shift of the main absorption peak, ∼30 nm, was
observed for mir21 compared to the Nc sequence (Fig. 1c)
upon addition of the PNA sequence complementary to mir21
(blue curve).
The fluorescence emission spectra show a significant
quenching of PT fluorescence upon exposure to mir21 and Nc
sequences. As observed from Fig. 1b and d, recovery of the
fluorescence upon addition of PNA is significantly higher for
mir21 in comparison with the Nc sequence, due to the change
from planar to a non-planar “random” backbone of PT in the
PT–PNA–mir21 triplex construct. The optical images of vials
containing PT with mir21 and with Nc sequences (insets in
Fig. 1a and c, respectively) indicate a similar colorimetric
response for the two sequences. However, recovery in the
colorimetric response is more evident for mir21 upon addition of
a complementary PNA sequence, in agreement with the UV-Vis
spectra (the red and blue curves in Fig. 1a and c). Fig. 1
ascertains that the optical shifts are consistent with the
duplex/triplex formation and that the synthesized PT could be
utilized as a responsive layer on QCM surface for miRNA assay.
Herein, we explore the potential of immobilizing PT on QCM
surfaces for specific and quantitative analysis of miRNA.
QCM assay
The proposed assay (Fig. 2) involves sequential injection of the
synthesized PT and BSA into the QCM chamber, followed by
miRNA and a complementary sequence of b-PNA for hybridi-
zation with the target miRNA sequence; ANPs are subsequently
utilized for amplified detection of miRNA. PT was injected
simultaneously into two chambers mounted with cleaned
QCM crystals. Upon injection of PT, a two-step frequency
response (Fig. 3(a) was observed) due to changes in the mor-
phology of PT upon buffer exchange between DI water and
PBST, in agreement with previous reports.24 The surface mass
coverage of the PT as revealed by SPR was estimated to be
Fig. 1 (a, b) Absorption and emission spectra with images (inset a) of PT with subsequent addition of mir21 followed by PNA; (c, d) absorption and
emission spectra with images (inset c) of PT with subsequent addition of the Nc sequence followed by PNA.
Fig. 2 Schematic illustration of the mir21 assay on QCM crystals.
Quartz crystal is sequentially exposed to (a) PT, (b) BSA for gold substrate
passivation, (c) RNA and duplex formation, (d) b-PNA and triplex for-
mation, and (e) ANP for signal amplification.
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∼158 ng cm−2; corresponding to a thickness of ∼2.8 nm and a
density of ∼1.2 × 1013 molecules cm−2, further indicating PT
immobilization on the QCM surface (see Fig. S3† for experi-
mental details). 5 mg ml−1 BSA in PBST was then injected for
substrate passivation in order to minimize physisorption of
ANP and other interfering species present in the complex
matrices on Au surfaces (b), if any. 10 µM of mir21 and 10 µM
of Nc sequences were then injected into chambers 1 and 2,
respectively. Identical resonance frequency shifts of ∼5 Hz (c)
were obtained for both mir21 and Nc sequences indicating
that the synthesized PT captures both Nc and mir21
sequences. 10 µM b-PNA complementary to mir21 was sub-
sequently injected into both channels, followed by injection
of ANP. Although no obvious frequency or dissipation shifts
(0.5 Hz and 0.27E6, respectively) were noticed upon b-PNA hybridi-
zation with mir21 (d), significant frequency and dissipation
shifts (20 Hz and 10E6, respectively) were observed upon injec-
tion of 0.1 mg ml−1 ANP (e). PNA–mir21–PT triplex formation
is therefore ascertained as only a negligible shift was recorded
for the Nc–PT duplex, indicating the successful capture of
miRNA by PT immobilized on the Au surface and selective
recognition of the mir21–PT duplex by b-PNA. As shown in
Fig. 3, approximately 40-fold signal amplification, a shift of
20 Hz upon ANP addition for mir21 compared to ∼0.5 Hz for
Nc sequence, was achieved by injection of ANP.
Selective detection of mir21
Concentration dependent responses (Fig. 4) reveal that fre-
quency shifts were observed only when mir21 is captured by
PT immobilized on the QCM surface. Almost negligible
responses were obtained for all test concentrations of Nc
sequence (curve Nc) indicating minimum interaction and
binding between Nc and b-PNA (complementary to mir21)/ANP.
A frequency shift of ∼5 Hz was obtained for 100 nM of mir21
compared to ∼0.5 Hz for 100 nM of the Nc sequence, illustrating
that incorporation of capture and amplification methodologies
enables selective detection of miRNA. Quantification of
miRNA is subsequently achieved by correlating frequency
responses with mir21 concentrations. As observed from Fig. 4,
frequency responses were obtained for 1 nM to 10 µM mir21,
with a limit of detection of 400 pM, calculated using 3σ/S,25
where σ is the standard deviation and S is the slope of the con-
centration response, derived at a lower linear response range
[between 1 nM and 10 nM, Fig. 4]. Repeatable frequency
responses for all test concentrations of mir21 and Nc (n = 3)
were obtained indicating the homogeneity in PT adsorption
on QCM surfaces. The proposed methodology therefore
illustrates the potential for analysis of complex samples con-
taining miRNA in the clinically relevant nM concentration
ranges.21,26,27
Fig. 3 QCM kinetic measurements: frequency (df) and energy dissipation (D) at the third overtone for (A) mir21 and (B) Nc sequence illustrating
responses after the injection of (a) PT, (b) BSA, (c) 10 µM mir21/Nc sequence, (d) b-PNA, and (e) 0.1 mg ml−1 ANP.
Fig. 4 Concentration dependent responses for mir21 and Nc
sequences (n = 3). Inset: QCM kinetic measurement for mir21 and Nc
sequences isolated from plasma (a) b-PNA, (b) 0.1 mg ml−1 ANP, and (c)
0.5 mg ml−1 ANP.
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mir21 assay in plasma
The mir21 assay was then carried out using plasma for demon-
strating the applicability of the proposed approach for complex
matrices. Plasma samples were spiked with 1 µM of mir21 to
mimic clinical samples. Commercially available extraction kits
were then used for miRNA isolation, in order to minimize the
potential interference associated with physisorption of plasma
components. mir21 isolation was carried out adopting the
standard protocol shown in Fig. S4.† For control measure-
ments, the same protocol was adopted for plasma samples
spiked with 1 µM of the Nc sequence. UV-Vis analysis was
carried out at each step of the isolation process to confirm
mir21 and Nc sequence extraction from the plasma samples
(Fig. S5†). The inset in Fig. 4 shows a negligible shift for the
plasma sample spiked with mir21 and Nc sequences upon
injection of b-PNA (a). Following the injection of 0.1 mg ml−1
ANP, a frequency shift of ∼2 Hz was observed for mir21 spiked
plasma samples (b) compared to a negligible shift for the
plasma samples spiked with the Nc sequence. The experi-
mental results indicate that amplification enhancement could
be achieved upon increasing the concentration of ANP. A
further increase in the frequency response ∼4 Hz (c) was
observed upon injection of 0.5 mg ml−1 ANP to the plasma
sample spiked with mir21. However, as observed from Fig. 4
inset, the increasing concentration of ANP resulted in higher
signal to noise ratios. Further studies will therefore focus
on optimization of assay and amplification protocols, empha-
sizing on the sensitivity and selectivity enhancement, for
instance, tailoring the terminal groups of PT for maximiz-
ing the RNA capture and assay. Nevertheless, the proposed
capture methodology enabled quantification of mir21 in
plasma samples without requiring PCR and sophisticated
instrumentation.
Conclusion
A cationic polythiophene derivative has been deposited on a
quartz resonator such as QCM for mir21 assay using b-PNA
and ANP amplification. The proposed methodology provides
an approach to capture all miRNA sequences in the sample
compared to conventional assays that quantify a specific
sequence of RNA. Successful detection of mir21 was carried
out at clinically relevant concentrations with a limit of detec-
tion of 400 pM. Since QCM offers portability, the proposed
methodology is feasible for the development of point of care
devices. Furthermore, the assay of other RNA sequences of
interest could be carried out upon utilization of appropriate
complementary PNA sequences.
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